In the recent 7th iSEE Global Awards, Wecare Probiotics' innovative strain, Bifidobacterium animalis subsp. lactis BLa80, was honored with a Top50 Innovative Technology Award.

Constipation affects millions globally, impacting daily comfort and well-being. But imagine finding relief through a natural, scientifically backed source that can seamlessly fit into your lifestyle.

New research suggests Wecare Probiotics' BLa80 as a potential natural sleep aid. This article details a study showing promising improvements in sleep quality through the use of this specific probiotic strain.

Latest research on Wecare's Akkermansia Muciniphila Akk11 has shown remarkable neuroprotective effects in a Parkinson's disease mouse model, indicating potential breakthrough application in precision medicine.

A new study from Wecare Probiotics indicates that Akkermansia muciniphila Akk11 may offer significant neuroprotective benefits in a mouse model of Parkinson's Disease (PD). Published in Probiotics and Antimicrobial Proteins, the research demonstrates Akk11's potential to mitigate neuronal damage and motor impairment.

At FHE2025, Dr. Devin Zhu, Vice President of R&D at Wecare Probiotics, delivered a presentation titled "Development and Scaled Intelligent Manufacturing of Industrialized and Functional Probiotic Strains."